Hepatic Dystrophic Calcification Secondary to Transarterial Chemoembolization: Case Report and Review of Literature

Hepatocellular carcinoma (HCC) is a common malignancy usually treated with surgery. Patients who are not suitable for surgery undergo transarterial chemoembolization (TACE) which involves injecting anti-cancer drugs and embolizing agents into the hepatic artery. Although it is a relatively safe proc...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2023-03, Vol.15 (3), p.e35765
Main Authors: Kumar, Vikash, Shah, Mili, Gala, Dhir, Singh, Manmeet K, Jeanty, Herby, Thomas, Reeny, Forlemu, Arnold N, Gayam, Vijay Reddy, Etienne, Denzil
Format: Article
Language:English
Subjects:
Abdomen
Ablation
Bile ducts
Calcification
Case reports
Chemoembolization
Chemotherapy
Embolisms
Family/General Practice
Fever
Gallbladder diseases
Gastroenterology
Internal Medicine
Liver cancer
Magnetic resonance imaging
Medicine
Metastasis
Mortality
Nausea
Pain
Pancreatitis
Patients
Surgery
Tomography
Tumors
Vital signs
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatocellular carcinoma (HCC) is a common malignancy usually treated with surgery. Patients who are not suitable for surgery undergo transarterial chemoembolization (TACE) which involves injecting anti-cancer drugs and embolizing agents into the hepatic artery. Although it is a relatively safe procedure with minor side effects, TACE can rarely cause dystrophic calcification in the liver. We report a case of a 58-year-old female who presented with right-sided chest pain. The patient had been previously treated for HCC with a TACE procedure. A chest x-ray revealed hepatic calcification which was likely secondary to the prior TACE. This case study emphasizes the significance of considering TACE as a potential cause of hepatic dystrophic calcification.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.35765